Cover Image

SARS-CoV-2 RBD Mutation Constellations (G339D, S375F, E484A, Q493R, L452R): Insights from Historical Data on Monoclonal Antibody Class 3 Escape Risk Measured from 2021 - 2023 Data

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Author:	Bhatti, Tahir
Format:	Recurso digital
Published:	Zenodo 2025
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mapping Potential Drug Resistance Mutations in SARS-CoV-2 nsp12 Motifs Q1 2025
by: Tahir, Bhatti
Published: (2025)

SARS-CoV-2 Spike Mutation Co-occurrence Network - Segment 3: Genomic Surveillance of Co-evolving Mutations in a Global Dataset
by: Tahir, Bhatti
Published: (2025)

Global Haplotype Landscape of SARS-CoV-2 Spike Contact Residues Reveals Dominant Escape Signatures and Systemic Sequencing Ambiguity
by: Bhatti, Tahir
Published: (2025)

GVAtlas: Pioneering Genomic Variant Analysis and Visualization for SARS CoV 2 and Beyond
by: Tahir, Bhatti, et al.
Published: (2025)

2024 SARS-CoV-2 Sequences with Diagnostic Primer/Probe Mismatch Profiles
by: Bhatti, Tahir
Published: (2025)

Immunoassay Detection of SARS ‐ CoV ‐2 Using Monoclonal Antibody Binding to Viral Nucleocapsid Protein
by: Robert M. Hnasko, et al.
Published: (2025)

Clinical Pharmacology Approaches to Predict Efficacy of Monoclonal Antibodies Against Emerging SARS ‐ CoV ‐2 Variants
by: Qianwen Wang, et al.
Published: (2025)

The Compensatory Effect of S375F on S371F Is Vital for Maintaining the Infectivity of SARS‐CoV‐2 Omicron Variants
by: Shuo Liu, et al.
Published: (2025)

Safety, Tolerability, and Pharmacokinetics of the Long‐Acting SARS‐CoV‐2–Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in Healthy Chinese Adults
by: Nanyang Li, et al.
Published: (2025)

Developments in the Production of Recombinant Monoclonal Antibodies
by: Debajyoti Saha, et al.
Published: (2025)

A Chip‐Based Surveillance Platform for Detecting Antibody‐Based Immunity and Immune Escape Using SARS‐CoV‐2 Pseudovirus Surrogates
by: Maisha M. Feroz, et al.
Published: (2025)

Genomic Insights Into Respiratory Syncytial Virus Circulation Patterns and Neutralization by Anti‐F Monoclonal Antibodies in Panama (2018–2024)
by: Danilo Franco, et al.
Published: (2025)

Quantitative Prediction of Protein-Polyelectrolyte Binding Thermodynamics: Adsorption of Heparin-Analog Polysulfates to the SARS-CoV-2 Spike Protein RBD
by: Neander, Lenard, et al.
Published: (2024)

Análisis in silico de las alteraciones de la secuencia y estructura de RBD-SARS-CoV-2, que afectan su complementariedad por anticuerpos neutralizantes IgG-antiRBD
by: Ricardo Enrique Grados-Torrez
Published: (2023)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
by: Swapna Thomas, et al.
Published: (2024)

Bebtelovimab‐bound SARS‐CoV‐2 RBD mutants: resistance profiling and validation with escape mutations, clinical results, and viral genome sequences
by: Khushboo Bhagat, et al.
Published: (2024)

A Novel Prophylaxis Strategy Using Ecotin as A Promising Adjuvant for Fc‐RBD Fusion Protein Vaccine of SARS ‐ CoV ‐2
by: Yakun Sun, et al.
Published: (2025)

IgG Monoclonal Antibodies: Analytical Perspectives
by: Dhruvi Nilesh Nirmal, et al.
Published: (2025)

452ºF
Published: (2017)

Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022
by: Ryan Sandford, et al.
Published: (2024)

Adaptabodies: Retargeting a Predefined Monoclonal Antibody With Bispecific Nanobodies for Antibody Therapy
by: Andrés González‐Techera, et al.
Published: (2025)

An Asymptotic Analysis of Bivalent Monoclonal Antibody-Antigen Binding
by: Heirene, Luke A, et al.
Published: (2025)

Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management
by: Akram N. Salah, et al.
Published: (2025)

Landscape of Subcutaneous Administration Strategies for Monoclonal Antibodies in Oncology
by: Guillaume Jacquot, et al.
Published: (2024)

Seroprevalence Trends of Antibodies to SARS‐CoV‐2 in South Korea, 2021–2022: A Repeated Cross‐Sectional Study
by: Ah‐Ra Kim, et al.
Published: (2025)

Non‐Neutralising Antibodies and T Cell Responses to SARS ‐ CoV ‐2 Detected in Unvaccinated SARS ‐ CoV ‐2‐Naive Spanish Adolescents
by: Hector F. Pelaez‐Prestel, et al.
Published: (2025)

Possible rapid reduction of anti‐RBD antibody titre after SARS‐CoV‐2 mRNA vaccination in pregnant women: Multicentre prospective study
by: Mamiko Ohta, et al.
Published: (2024)

PETRA: Pretrained Evolutionary Transformer for SARS-CoV-2 Mutation Prediction
by: Zou, Xu
Published: (2025)

Monoclonal Antibody 5F1 Modulates Formyl Peptide Receptor 1 Conformation for Transmembrane Signaling
by: Yue Wang, et al.
Published: (2025)

Quantitative Prediction of Human Pharmacokinetics for Fc‐Engineered Therapeutic Monoclonal Antibodies With Increased FcRn Binding Mutations After Subcutaneous Injection
by: Kenta Haraya, et al.
Published: (2026)

Design and Implementation of an EWMA Control Chart for Zero‐Inflated Count Data in High‐Quality Processes
by: Muhammad Ali Raza, et al.
Published: (2025)

Cross‐Reactivity of SARS ‐ CoV ‐2 Antibodies With Typhoid Flagellar‐H Protein
by: Aneela Pasha, et al.
Published: (2025)

Self‐Driving Development of Perfusion Processes for Monoclonal Antibody Production
by: Chethana Janardhana Gadiyar, et al.
Published: (2025)

Rapid Purification Strategies for Monoclonal Antibodies: A Case Study
by: Qian Li, et al.
Published: (2025)

Generation of Conformation‐Specific Monoclonal Antibodies for Integral Membrane Proteins
by: Natalie Sheldon, et al.
Published: (2025)

Two Murine Monoclonal Antibodies against Serogroup E Salmonellae
by: S. P. Ng, R. S. W. Tsang, J. M. C. Luk, M. H. Ng, And S. W. K. Im
Published: (2000)

A Case With Concurrent Monoclonal Gammopathy, Thrombocytopenia, and Antiphospholipid Antibodies
by: Zhan Su, et al.
Published: (2026)

Monoclonal Antibodies During Breastfeeding—Challenges With Relative Infant Dose
by: Paulina Flis, et al.
Published: (2025)

Community RSV Surveillance in the Long‐Acting Monoclonal Antibody Era
by: David Anthony Foley
Published: (2026)

Expanding Access to Monoclonal Antibody Treatment by the Adoption of Biosimilar Agents
by: Michael Goggin
Published: (2025)